Emami vs Peers
- Market cap
- ₹16,356 crore
- P/E
- 21.9
- P/B
- 5.59
- ROE
- 27.6%
- Dividend yield
- 1.20%
Emami ranks 6th by market capitalisation among 8 Personal Care companies tracked by ATS. Its largest peers are Godrej Consumer Products, Dabur India and Colgate Palmolive (India). Its P/E of 21.9 compares with a peer median of 35.7.
Emami vs Personal Care peers
Sorted by market capitalisation.
| Company | Close (₹) | 1D | Market cap (₹ cr) | P/E | P/B | ROE | 1Y return |
|---|---|---|---|---|---|---|---|
| Godrej Consumer Products | 866.00 | -0.74% | 88,613 | 46.3 | 7.00 | 15.1% | +12.5% |
| Dabur India | 384.35 | -1.17% | 68,172 | 34.6 | 5.97 | 17.1% | +12.5% |
| Colgate Palmolive (India) | 1,768.00 | -2.29% | 48,087 | 35.7 | 30.36 | 81.6% | +12.5% |
| Cupid | 344.95 | +6.40% | 46,384 | 337.7 | 102.89 | 27.3% | +12.5% |
| Gillette India | 7,153.00 | +1.36% | 23,308 | 34.9 | 24.63 | 68.2% | +12.5% |
| Emami | 374.70 | -2.42% | 16,356 | 21.9 | 5.59 | 27.6% | +22.0% |
| Honasa Consumer | 472.35 | -1.24% | 15,369 | 61.8 | 10.89 | 15.4% | +12.5% |
| Bajaj Consumer Care | 484.20 | -1.88% | 6,325 | 28.4 | 8.38 | 25.3% | +12.5% |
Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.
Emami peer comparison — frequently asked questions
Who are Emami's competitors?
Emami's listed peers in Personal Care include Godrej Consumer Products, Dabur India, Colgate Palmolive (India), Cupid, Gillette India and Honasa Consumer, ranked here by market capitalisation.
How does Emami's P/E compare with its peers?
Emami trades at a P/E of 21.9, against a median of 35.7 across the 7 Personal Care peers shown.
Which is the largest company among Emami's peers?
By market capitalisation, the largest company in the group is Godrej Consumer Products at ₹88,613 crore, against ₹16,356 crore for Emami.
Same Data For Peers
Trade Emami With ATS
Track EMAMILTD live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.